Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3350)
All Articles published online
|
Apr 28, 2011 (publication date) through Nov 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chang CS, Yan SL, Lin HY, Yu FL, Tsai CY. Pure red cell aplasia caused by pegylated interferon-α-2a plus ribavirin in the treatment of chronic hepatitis C. World J Gastroenterol 2011; 17(16): 2155-2158 [PMID: 21547138 DOI: 10.3748/wjg.v17.i16.2155] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i16/2155.htm |
| Number | Citing Articles |
| 1 |
Naba R Mainali, Vijaya R Bhatt, Shiksha Kedia, Jairam Krishnamurthy, Laura M Wake, Mojtaba Akhtari. Reversible bone marrow aplasia induced by pegylated interferon-α-2a therapy in a patient with primary myelofibrosis. Journal of Oncology Pharmacy Practice 2014; 20(5): 386 doi: 10.1177/1078155213504444
|
| 2 |
Scott C Quinlan, Jennifer C.L Hawes, Daniel Mines, Shirin Ahmed, Stephan Lanes, Vinay Mehta, Crystal N Holick, Nancy Santanello, T Christopher Mast. Performance of an administrative claims algorithm to estimate the incidence of pure red cell aplasia in chronic hepatitis C patients. Epidemiology Reports 2015; 3(1): 1 doi: 10.7243/2054-9911-3-1
|
| 3 |
Keiji Hirai, Susumu Ookawara, Haruhisa Miyazawa, Kiyonori Ito, Yuichiro Ueda, Yoshio Kaku, Taro Hoshino, Shun-ichi Kimura, Izumi Yoshida, Sachiko Kakuta, Yoshiyuki Morishita, Kaoru Tabei. Successful treatment of a hemodialyzed patient with pure red cell aplasia associated with epoetin beta pegol therapy with cyclosporine. CEN Case Reports 2016; 5(1): 78 doi: 10.1007/s13730-015-0196-8
|
| 4 |
|
| 5 |
Gwen Masclee, Jeffrey K. Aronson. A worldwide yearly survey of new data in adverse drug reactions and interactions. Side Effects of Drugs Annual 2014; 35: 659 doi: 10.1016/B978-0-444-62635-6.00037-1
|
| 6 |
Jian-Wu Yu, Li-Jie Sun, Yong-Hua Zhao, Peng Kang, Bing-Zhu Yan. The study of relationship between neutropenia and infection during treatment with peginterferon α and ribavirin for chronic hepatitis C. European Journal of Gastroenterology & Hepatology 2011; 23(12): 1192 doi: 10.1097/MEG.0b013e32834c5b32
|
| 7 |
I.D. Ramsay, J.M. Lestner, C.I.S. Barker. A worldwide yearly survey of new data in adverse drug reactions and interactions. Side Effects of Drugs Annual 2014; 35: 503 doi: 10.1016/B978-0-444-62635-6.00029-2
|
| 8 |
Chenue Abongwa, Ghada Abusin, Ayman El‐Sheikh. Successful treatment of tacrolimus‐related pure red cell aplasia and autoimmune hemolytic anemia with rituximab in a pediatric cardiac transplant patient. Pediatric Blood & Cancer 2017; 64(12) doi: 10.1002/pbc.26674
|
| 9 |
Javier Ampuero, José Antonio Del Campo, Lourdes Rojas, José Luis Calleja, Joaquín Cabezas, Sabela Lens, Javier Crespo, Xavier Forns, Raúl J. Andrade, Inmaculada Fernández, María Buti, Raquel Millán, Manuel Romero-Gómez. Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment. Journal of Clinical Virology 2015; 68: 56 doi: 10.1016/j.jcv.2015.05.010
|
| 10 |
Annie K. Hung, Jennifer Guy, Caroline M. Behler, Eugene E. Lee. Anti-Erythropoietin Antibody Associated Pure Red Cell Aplasia Resolved after Liver Transplantation. Case Reports in Transplantation 2015; 2015: 1 doi: 10.1155/2015/286276
|
| 11 |
Brian A. Baldo. Side Effects of Cytokines Approved for Therapy. Drug Safety 2014; 37(11): 921 doi: 10.1007/s40264-014-0226-z
|